Toyonaka, Japan

Yasunori Mitsuoka


 

Average Co-Inventor Count = 4.1

ph-index = 2

Forward Citations = 15(Granted Patents)


Location History:

  • Osaka, JP (2021)
  • Toyonaka, JP (2014 - 2023)

Company Filing History:

goldMedal5 out of 1,001 
 
Shionogi Company Limited
 patents
silverMedal1 out of 1 
 
E-na Biotec Inc.
 patent
bronzeMedal1 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 2014-2023

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: **Yasunori Mitsuoka: A Pioneer in Nucleic Acid Medicine**

Introduction

Yasunori Mitsuoka, a notable inventor based in Toyonaka, Japan, has made significant contributions in the field of nucleic acid medicine. With a solid portfolio of six patents, his innovations are paving the way for advancements in therapeutic treatments. His latest inventions demonstrate a commitment to enhancing the efficacy of nucleic acid-based therapies.

Latest Patents

Mitsuoka's most recent patents include groundbreaking creations aimed at improving the effect of nucleic acid medicines. One such invention is a complex that incorporates multibranched lipids linked to oligonucleotide strands, particularly those associated with gene expression suppression. This novel complex serves to enhance the effectiveness of nucleic acid treatments. Additionally, he has developed derivatives of MicroRNA-143, which hold promise as oligonucleotide therapeutics, further highlighting his innovative approach to gene therapy.

Career Highlights

Throughout his career, Yasunori Mitsuoka has collaborated with prominent corporations such as Shionogi & Company Limited and E-na Biotec Inc. His work within these organizations has been crucial in translating theoretical concepts into practical applications in the medical field. Mitsuoka's six patents underscore his dedication to advancing medical technology and improving patient outcomes.

Collaborations

Mitsuoka's innovative journey has been supported by collaborations with talented colleagues, including Akira Kugimiya and Mitsuaki Sekiguchi. Together, they have contributed to the research and development of advanced therapeutic solutions, further enhancing the impact of their combined expertise in nucleic acid medicine.

Conclusion

Yasunori Mitsuoka stands out as a pivotal figure in the realm of medical innovation, particularly in nucleic acid therapies. His ongoing efforts to create effective therapeutic complexes and derivatives demonstrate a strong commitment to improving healthcare solutions. With a promising portfolio of patents and collaborations, Mitsuoka continues to inspire future innovations in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…